Company intelligence / Profile preview

Volnay Therapeutics

Ownership: Private
Development stage: Other

Overview

Volnay Therapeutics operates as a biotech venture builder focused on accelerating the development of innovative cell and gene therapies. It identifies promising therapeutic assets and enabling technologies, providing both capital investment and operational expertise to drive these ventures forward. The company emphasizes innovation in product manufacturing, commercial viability, and capital efficiency. Recent activities include partnering with March Biosciences to support the development of autologous CAR-T therapies for T-cell lymphomas.

Therapeutic areas: Oncology
Modalities: Cell therapiesGene therapies
Industry: Investors

Partnerships

March Biosciences (technical oversight/manufacturing partnership for MB‑105 autologous CAR-T program)

Beyond the preview

Go deeper on Volnay Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Volnay Therapeutics.